Company profile
CRISPR Therapeutics AG Insider Trading
CRSPEvery SEC Form 4 insider trading filing for CRISPR Therapeutics AG (CRSP) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001674416
- Filings
- 128
- Insiders
- 16
- Last filing
- 2026-09-22
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $781K across 1 transaction.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. CRISPR Therapeutics AG insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $77.1M.
90 day insight
Over the last 90 days, CRISPR Therapeutics AG insiders sold $781K across 1 transaction with no open-market purchases.
- Most active insider: Ali Behbahani with 3 transactions totaling $1.2M.
- Largest single sale: $781K by Ali Behbahani on Sep 17, 2026.
- 50% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | James R. Kasinger | CRSP | Option Exercise | 10,400 | $13.62 | $142K |
| Sep 22, 2026 | James R. Kasinger | CRSP | Sale10b5 | 10,400 | $60.24 | $626K |
| Sep 22, 2026 | James R. Kasinger | CRSP | Option Exercise | 10,400 | — | — |
| Sep 17, 2026 | Ali Behbahani | CRSP | Option Exercise | 30,000 | $14.00 | $420K |
| Sep 17, 2026 | Ali Behbahani | CRSP | Sale | 13,679 | $57.09 | $781K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=CRSP" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By open-market value traded.